Director, Institute of Biomedical and Pharmaceutical Research, Germany
Fritz Sorgel works as the Director, Institute of Biomedical and Pharmaceutical Research, Germany. he has written an editorial on Journal of Bioequivalence & Bioavailability.
His current research is on Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections
Editorial Note
Editorial Note for Journal of Bioequivalence & Bioavailability
Author(s): Fritz Sorgel*